In addition, EGFL7 overexpression was correlated with tumor size and recurrence, which means that EGFL7 may be considered a potential marker for assessing tumor behavior and the target of future anti-tumoral treatment [115]. The gene discussed is EGFL7; the disease is neoplasm.